1. Home
  2. PMN
  3. PMN News

Latest ProMIS Neurosciences Inc. (ON) (PMN) News on August 17, 2025

ProMIS Neurosciences Announces Second Quarter 2025 Financial Results & Corporate Highlights
PMN

GlobeNewswire

4 days ago

ProMIS Neurosciences Announces Second Quarter 2025 Financial Results & Corporate Highlights

Phoenix Mecano AG's (VTX:PMN) Intrinsic Value Is Potentially 46% Above Its Share Price
PMN

Simply Wall St.

2 months ago

Phoenix Mecano AG's (VTX:PMN) Intrinsic Value Is Potentially 46% Above Its Share Price

ProMIS Neurosciences Presents at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference
PMN

GlobeNewswire

2 months ago

ProMIS Neurosciences Presents at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference

ProMIS Neurosciences Announces First Quarter 2025 Financial Results
PMN

GlobeNewswire

3 months ago

ProMIS Neurosciences Announces First Quarter 2025 Financial Results

ProMIS Neurosciences Announces Full Year 2024 Financial Results and Recent Highlights
PMN

GlobeNewswire

5 months ago

ProMIS Neurosciences Announces Full Year 2024 Financial Results and Recent Highlights

ProMIS Neurosciences Showcases Preclinical Data on Platform-Derived Antibody and Vaccines for Neurodegenerative Diseases at Alzheimer’s Disease/Parkinson’s Disease 2025 International Conference
PMN

GlobeNewswire

5 months ago

ProMIS Neurosciences Showcases Preclinical Data on Platform-Derived Antibody and Vaccines for Neurodegenerative Diseases at Alzheimer’s Disease/Parkinson’s Disease 2025 International Conference

ProMIS Neurosciences Showcases Preclinical Data on Platform Derived Vaccines for Neurodegenerative Diseases at the American Academy of Neurology 2025 Annual Meeting
PMN

GlobeNewswire

5 months ago

ProMIS Neurosciences Showcases Preclinical Data on Platform Derived Vaccines for Neurodegenerative Diseases at the American Academy of Neurology 2025 Annual Meeting

ProMIS Neurosciences to Participate in the 37th Annual Roth Conference
PMN

GlobeNewswire

5 months ago

ProMIS Neurosciences to Participate in the 37th Annual Roth Conference

ProMIS Neurosciences Doses First Patients in Phase 1b PRECISE-AD Trial of PMN310 for Alzheimer’s Disease
PMN

GlobeNewswire

6 months ago

ProMIS Neurosciences Doses First Patients in Phase 1b PRECISE-AD Trial of PMN310 for Alzheimer’s Disease

ProMIS Neurosciences to Participate in Guggenheim Securities SMID Cap Biotech Conference
PMN

GlobeNewswire

7 months ago

ProMIS Neurosciences to Participate in Guggenheim Securities SMID Cap Biotech Conference

ProMIS Neurosciences Issues Letter to Shareholders
PMN

GlobeNewswire

7 months ago

ProMIS Neurosciences Issues Letter to Shareholders

ProMIS Neurosciences Initiates Phase 1b Clinical Trial (PRECISE-AD) in Alzheimer’s Disease
PMN

GlobeNewswire

7 months ago

ProMIS Neurosciences Initiates Phase 1b Clinical Trial (PRECISE-AD) in Alzheimer’s Disease

ProMIS Neurosciences to Participate in 7th Annual Evercore HealthCONx Conference
PMN

GlobeNewswire

9 months ago

ProMIS Neurosciences to Participate in 7th Annual Evercore HealthCONx Conference

ProMIS Neurosciences Announces Third Quarter 2024 Financial Results and Recent Highlights
PMN

GlobeNewswire

9 months ago

ProMIS Neurosciences Announces Third Quarter 2024 Financial Results and Recent Highlights

ProMIS Neurosciences to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference
PMN

GlobeNewswire

9 months ago

ProMIS Neurosciences to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference

ProMIS Neurosciences Presents Positive Data from PMN310 Phase1a Clinical Trial at the 17th Clinical Trials on Alzheimer’s Disease Conference
PMN

GlobeNewswire

10 months ago

ProMIS Neurosciences Presents Positive Data from PMN310 Phase1a Clinical Trial at the 17th Clinical Trials on Alzheimer’s Disease Conference

ProMIS Neurosciences to Showcase PMN310’s Ability to Target Toxic Oligomers and Distinguish from Other Amyloid-Beta Oligomers in Preclinical Studies at the 4th International Conference on Cognitive & Behavioral Neurosciences
PMN

GlobeNewswire

a year ago

ProMIS Neurosciences to Showcase PMN310’s Ability to Target Toxic Oligomers and Distinguish from Other Amyloid-Beta Oligomers in Preclinical Studies at the 4th International Conference on Cognitive & Behavioral Neurosciences

ProMIS Neurosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference
PMN

GlobeNewswire

a year ago

ProMIS Neurosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference

ProMIS Neurosciences Announces Second Quarter 2024 Financial Results and Recent Highlights
PMN

GlobeNewswire

a year ago

ProMIS Neurosciences Announces Second Quarter 2024 Financial Results and Recent Highlights

ProMIS Neurosciences Announces Data on the Pathogenic Role of Toxic Misfolded SOD1 Aggregates in ALS Published in Acta Neuropathologica and Open Biology
PMN

GlobeNewswire

a year ago

ProMIS Neurosciences Announces Data on the Pathogenic Role of Toxic Misfolded SOD1 Aggregates in ALS Published in Acta Neuropathologica and Open Biology

ProMIS Neurosciences to Participate in BTIG Virtual Biotechnology Conference 2024
PMN

GlobeNewswire

a year ago

ProMIS Neurosciences to Participate in BTIG Virtual Biotechnology Conference 2024

ProMIS Neurosciences Showcases Novel Vaccine Approach for Maximal Targeting of Toxic Amyloid-Beta Oligomers at the 2024 Alzheimer’s Association International Conference
PMN

GlobeNewswire

a year ago

ProMIS Neurosciences Showcases Novel Vaccine Approach for Maximal Targeting of Toxic Amyloid-Beta Oligomers at the 2024 Alzheimer’s Association International Conference

ProMIS Neurosciences Reports Positive Top-Line Data from its Phase 1a Alzheimer's Trial
PMN

GlobeNewswire

a year ago

ProMIS Neurosciences Reports Positive Top-Line Data from its Phase 1a Alzheimer's Trial

ProMIS Neurosciences Announces Up to $122.7 Million Private Placement Financing
PMN

GlobeNewswire

a year ago

ProMIS Neurosciences Announces Up to $122.7 Million Private Placement Financing

FDA panel votes to recommend Eli Lilly's Alzheimer's drug
PMN

Yahoo Finance Video

a year ago

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

PMN

GlobeNewswire

a year ago

Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis

California seeks company profits in Big Oil climate lawsuit
PMN

Reuters

a year ago

California seeks company profits in Big Oil climate lawsuit

PMN

USA TODAY

a year ago

S&P 500, Nasdaq post record closing highs; Fed meeting, CPI ahead

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock
PMN

Business Wire

a year ago

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis
PMN

GlobeNewswire

a year ago

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research
PMN

GlobeNewswire

a year ago

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas
PMN

Business Wire

a year ago

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

ProMIS Neurosciences Announces First Quarter 2024 Financial Results and Recent Highlights
PMN

GlobeNewswire

a year ago

ProMIS Neurosciences Announces First Quarter 2024 Financial Results and Recent Highlights

ProMIS Neurosciences Publishes Study Highlighting Oligomer Selectivity and Benefit of Amyloid-Beta-Directed Antibodies
PMN

GlobeNewswire

a year ago

ProMIS Neurosciences Publishes Study Highlighting Oligomer Selectivity and Benefit of Amyloid-Beta-Directed Antibodies

ProMIS Neurosciences Publishes in the Journal of Biological Chemistry on the Interaction Between Pathogenic Proteins as a Treatment Target for ALS
PMN

GlobeNewswire

a year ago

ProMIS Neurosciences Publishes in the Journal of Biological Chemistry on the Interaction Between Pathogenic Proteins as a Treatment Target for ALS

ProMIS Neurosciences to Present in Upcoming Investor Conferences in April
PMN

GlobeNewswire

a year ago

ProMIS Neurosciences to Present in Upcoming Investor Conferences in April

ProMIS Neurosciences Announces Full Year 2023 Financial Results and Recent Highlights
PMN

GlobeNewswire

a year ago

ProMIS Neurosciences Announces Full Year 2023 Financial Results and Recent Highlights

ProMIS Neurosciences Strengthens Global Intellectual Property Portfolio
PMN

GlobeNewswire

a year ago

ProMIS Neurosciences Strengthens Global Intellectual Property Portfolio

ProMIS Neurosciences to Present at the 2024 BIO CEO & Investor Conference
PMN

GlobeNewswire

a year ago

ProMIS Neurosciences to Present at the 2024 BIO CEO & Investor Conference

Invitae Partners with BridgeBio Pharma to Harness Genetic Insights for the Discovery of Rare Disease Therapeutics
PMN

PR Newswire

2 years ago

Invitae Partners with BridgeBio Pharma to Harness Genetic Insights for the Discovery of Rare Disease Therapeutics

PMN

Argus Research

2 years ago

Daily – Vickers Top Insider Picks for 01/30/2024

PMN

Argus Research

2 years ago

Daily – Vickers Top Insider Picks for 01/29/2024

Pro-Dex (NASDAQ:PDEX) shareholders have earned a 7.2% CAGR over the last five years
PMN

Simply Wall St.

2 years ago

Pro-Dex (NASDAQ:PDEX) shareholders have earned a 7.2% CAGR over the last five years

PMN

Associated Press Finance

2 years ago

Bassett: Fiscal Q4 Earnings Snapshot

Bassett Announces Fiscal Fourth Quarter Results
PMN

GlobeNewswire

2 years ago

Bassett Announces Fiscal Fourth Quarter Results

INTEGRA INTERSECTS 4.07 g/t AuEq OVER 41 M AND 0.91 g/t AuEq OVER 157 M IN METALLURIGICAL DRILL PROGRAM AT DELAMAR
PMN

CNW Group

2 years ago

INTEGRA INTERSECTS 4.07 g/t AuEq OVER 41 M AND 0.91 g/t AuEq OVER 157 M IN METALLURIGICAL DRILL PROGRAM AT DELAMAR

ProMIS Neurosciences Achieves Milestone in Development of Therapeutic Alpha-Synuclein Vaccine
PMN

GlobeNewswire

2 years ago

ProMIS Neurosciences Achieves Milestone in Development of Therapeutic Alpha-Synuclein Vaccine

Invitae sells reproductive health assets amid liquidity concerns
PMN

MedTech Dive

2 years ago

Invitae sells reproductive health assets amid liquidity concerns

Ohio Valley Banc Corp. (NASDAQ:OVBC) Looks Like A Good Stock, And It's Going Ex-Dividend Soon
PMN

Simply Wall St.

2 years ago

Ohio Valley Banc Corp. (NASDAQ:OVBC) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

Phunware Announces Pricing of $5.6 Million Registered Direct Offering
PMN

GlobeNewswire

2 years ago

Phunware Announces Pricing of $5.6 Million Registered Direct Offering

The 3 Most Undervalued EV Charging Stocks to Buy in January
PMN

InvestorPlace

2 years ago

The 3 Most Undervalued EV Charging Stocks to Buy in January

Myomo Reports Preliminary Fourth Quarter Revenue and Backlog
PMN

Business Wire

2 years ago

Myomo Reports Preliminary Fourth Quarter Revenue and Backlog

Best EV Stock 2024: QuantumScape Stock vs. Canoo Stock
PMN

Motley Fool

2 years ago

Best EV Stock 2024: QuantumScape Stock vs. Canoo Stock

OneConnect Announces Extraordinary General Meeting Results
PMN

PR Newswire

2 years ago

OneConnect Announces Extraordinary General Meeting Results

Globalink Investment Inc. Announces Extension of the Deadline to Complete a Business Combination to February 9, 2024
PMN

GlobeNewswire

2 years ago

Globalink Investment Inc. Announces Extension of the Deadline to Complete a Business Combination to February 9, 2024

ProMIS Neurosciences Issues Letter to Shareholders
PMN

GlobeNewswire

2 years ago

ProMIS Neurosciences Issues Letter to Shareholders

4 Stocks in Focus That Recently Hiked Their Dividends
PMN

Zacks

2 years ago

4 Stocks in Focus That Recently Hiked Their Dividends

Acrivon Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
PMN

GlobeNewswire

2 years ago

Acrivon Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

ProMIS Neurosciences, Inc. Announces Leadership Transition
PMN

GlobeNewswire

2 years ago

ProMIS Neurosciences, Inc. Announces Leadership Transition

Stronghold Announces Addition of up to ~1 EH/s Through Bitcoin Miner Purchases and an Option to Purchase Bitcoin Miners
PMN

GlobeNewswire

2 years ago

Stronghold Announces Addition of up to ~1 EH/s Through Bitcoin Miner Purchases and an Option to Purchase Bitcoin Miners

APX Acquisition Corp. I receives Nasdaq notice on late filing of its Form 10-Q
PMN

PR Newswire

2 years ago

APX Acquisition Corp. I receives Nasdaq notice on late filing of its Form 10-Q

Manhattan Bridge Capital, Inc. Announces Payment of Quarterly Dividend
PMN

GlobeNewswire

2 years ago

Manhattan Bridge Capital, Inc. Announces Payment of Quarterly Dividend

7 Under-the-Radar Stocks Gearing Up for a 2025 Breakthrough
PMN

InvestorPlace

2 years ago

7 Under-the-Radar Stocks Gearing Up for a 2025 Breakthrough

Autonomous trucking 2023: Leaders emerge amid exits and entries
PMN

FreightWaves

2 years ago

Autonomous trucking 2023: Leaders emerge amid exits and entries

ProMIS Neurosciences Announces Publication on Novel Target for ALS
PMN

GlobeNewswire

2 years ago

ProMIS Neurosciences Announces Publication on Novel Target for ALS

Crexendo Continues Rapid Growth, Surpasses Four Million Users
PMN

ACCESSWIRE

2 years ago

Crexendo Continues Rapid Growth, Surpasses Four Million Users

PRINCIPAL REAL ESTATE INCOME FUND CONTINUES SHARE REPURCHASE PROGRAM
PMN

PR Newswire

2 years ago

PRINCIPAL REAL ESTATE INCOME FUND CONTINUES SHARE REPURCHASE PROGRAM

Here Is Why Bargain Hunters Would Love Fast-paced Mover ACRES Commercial (ACR)
PMN

Zacks

2 years ago

Here Is Why Bargain Hunters Would Love Fast-paced Mover ACRES Commercial (ACR)

Globalink Investment Inc. Announces Extension of the Deadline to Complete a Business Combination to December 9, 2023
PMN

GlobeNewswire

2 years ago

Globalink Investment Inc. Announces Extension of the Deadline to Complete a Business Combination to December 9, 2023

Babcock & Wilcox Enterprises (NYSE:BW) Is Doing The Right Things To Multiply Its Share Price
PMN

Simply Wall St.

2 years ago

Babcock & Wilcox Enterprises (NYSE:BW) Is Doing The Right Things To Multiply Its Share Price

Sidoti Events, LLC's Virtual December Small-Cap Conference
PMN

ACCESSWIRE

2 years ago

Sidoti Events, LLC's Virtual December Small-Cap Conference

SP Plus Corporation Awarded Five-Year Contract at San Francisco International Airport
PMN

GlobeNewswire

2 years ago

SP Plus Corporation Awarded Five-Year Contract at San Francisco International Airport

WalkMe (WKME) Upgraded to Buy: Here's Why
PMN

Zacks

2 years ago

WalkMe (WKME) Upgraded to Buy: Here's Why

Key Information Relating to the Cash Dividend to Be Paid by Cool Company Ltd. (TICKER: CLCO)
PMN

Business Wire

2 years ago

Key Information Relating to the Cash Dividend to Be Paid by Cool Company Ltd. (TICKER: CLCO)

TriCo Bancshares Announces Quarterly Cash Dividend
PMN

Business Wire

2 years ago

TriCo Bancshares Announces Quarterly Cash Dividend

Zacks Industry Outlook Highlights Citizens Community, First Savings Financial and Provident Financial Services
PMN

Zacks

2 years ago

Zacks Industry Outlook Highlights Citizens Community, First Savings Financial and Provident Financial Services

PMN

PR Newswire

2 years ago

BioLineRx Reports Third Quarter 2023 Financial Results and Recent Corporate and Portfolio Updates

ProMIS Neurosciences Doses First Subjects in Phase 1a Clinical Trial of PMN310 to Treat Alzheimer’s Disease
PMN

GlobeNewswire

2 years ago

ProMIS Neurosciences Doses First Subjects in Phase 1a Clinical Trial of PMN310 to Treat Alzheimer’s Disease

CSI Compressco to Present at the Bank of America Leveraged Finance Conference
PMN

PR Newswire

2 years ago

CSI Compressco to Present at the Bank of America Leveraged Finance Conference

Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors
PMN

GlobeNewswire

2 years ago

Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors

MDB Capital Holdings Reports Third Quarter 2023 Results
PMN

GlobeNewswire

2 years ago

MDB Capital Holdings Reports Third Quarter 2023 Results

PMN

GuruFocus.com

2 years ago

Cormedix Inc (CRMD) Reports Increased Operating Expenses Amid Pre-Launch Activities in Q3 2023

ProMIS Neurosciences Announces Third Quarter 2023 Financial Results and Recent Highlights
PMN

GlobeNewswire

2 years ago

ProMIS Neurosciences Announces Third Quarter 2023 Financial Results and Recent Highlights

CorMedix Inc. Reports Third Quarter and Nine Month 2023 Financial Results and Provides Business Update
PMN

GlobeNewswire

2 years ago

CorMedix Inc. Reports Third Quarter and Nine Month 2023 Financial Results and Provides Business Update

ACCO Brands Announced as One of America’s Safest Companies for 2023 by EHS Today
PMN

Business Wire

2 years ago

ACCO Brands Announced as One of America’s Safest Companies for 2023 by EHS Today

BioLineRx to Report Third Quarter 2023 Results on November 20, 2023
PMN

PR Newswire

2 years ago

BioLineRx to Report Third Quarter 2023 Results on November 20, 2023

Independent Director of Eastern Picks Up 9.7% More Stock
PMN

Simply Wall St.

2 years ago

Independent Director of Eastern Picks Up 9.7% More Stock

PMN

GlobeNewswire

2 years ago

Silver Spike Investment Corp. Reports Third Quarter 2023 Financial Results

InfuSystem to Participate at 14th Annual Craig-Hallum Alpha Select Conference on November 16, 2023
PMN

Business Wire

2 years ago

InfuSystem to Participate at 14th Annual Craig-Hallum Alpha Select Conference on November 16, 2023

PMN

GuruFocus.com

2 years ago

The Oncology Institute Inc (TOI) Reports Q3 2023 Results: Revenue Up, Net Loss Widens

The Oncology Institute Reports Third Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance
PMN

GlobeNewswire

2 years ago

The Oncology Institute Reports Third Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance

Share on Social Networks: